Keywords: لاموتریژین; AE; autoimmune epilepsy; AED; antiepileptic drug; IMT; immunotherapy; CBZ; carbamazepine; LCM; lacosamide; LTG; lamotrigine; LEV; levetiracetam; OXZ; oxcarbazepine; PHT; phenytoin; Autoimmune epilepsy;
مقالات ISI لاموتریژین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لاموتریژین; Lamotrigine; Long-term monotherapy; Typical absence seizures; Children; Efficacy; Safety;
Keywords: لاموتریژین; Lamotrigine; Cyclic voltammetry; Chronoamperometry; Boron-doped diamond; Microelectrode;
Keywords: لاموتریژین; ACC; anterior cingulate cortex; AEDs; ntiepileptic drugs; BPRS; Brief Psychiatric Rating Scale; CBZ; carbamazepine; CZP; clonazepam; EP+DS; epilepsy patients with depressive symptoms; EP-DS; epilepsy patients without depressive symptoms; FC; functional co
Keywords: لاموتریژین; Eutimizantes; Litio; Ácido valproico; Carbamazepina; Lamotrigina; Embarazo; Lactancia; Mood stabilisers; Lithium; Valproic acid; Carbamazepine; Lamotrigine; Pregnancy; Breastfeeding;
Keywords: لاموتریژین; Mood stabilizers; Cataract; Lithium; Valproate; Carbamazepine; Lamotrigine;
Keywords: لاموتریژین; Seizures; Epilepsy; Lamotrigine; Assisted reproduction; Gonadotropins; Ovarian stimulation;
Keywords: لاموتریژین; Lamotrigine; Valproate; Drug interactions; Pharmacokinetics; Epilepsy;
Keywords: لاموتریژین; AED; antiepileptic drug; CBZ; carbamazepine; CLB; clobazam; CZP; clonazepam; ESL; eslicarbazepine acetate; GBP; gabapentin; ILAE; International League Against Epilepsy; LCM; lacosamide; LEV; levetiracetam; LTG; Lamotrigine; Na; sodium; OXC; oxcarbazepine;
Keywords: لاموتریژین; AED; anti-epileptic drug; CBZ; carbamazepine; CI; confidence Interval; CLB; clobazam; GTCS; generalized tonic clonic seizures; ILAE; International League Against Epilepsy; KREP; Kerala Registry for Epilepsy and Pregnancy; LMP; last menstrual period; LEV;
Keywords: لاموتریژین; Controlled-release carbamazepine; Efficacy; Lamotrigine; Levetiracetam; Poststroke epilepsy; Tolerability;
Keywords: لاموتریژین; ADAM; advanced dissolution, absorption, and metabolism; AED; antiepileptic drug; AUC; area-under-the-curve; B/P; blood to plasma ratio; BID; twice daily; BMI; body mass index; CBZ; carbamazepine; CLint; intrinsic clearance; CLR; renal clearance; CL; clear
Keywords: لاموتریژین; AED; anti-epileptic drug; CMZ; carbamazepine; GTK; generalized tonic-clonic seizure; EEG; electroencephalography; IQ; intelligence quotient; LEV; levetiracetam; LTG; lamotrigine; MRI; magnetic resonance imaging; PER; perampanel; PET; positron emission tom
Keywords: لاموتریژین; Bipolar disorder; Lamotrigine; Lithium; Pregnancy; Recurrence; Postpartum;
Keywords: لاموتریژین; Lamotrigine; Phenytoin; Celecoxib; Tween 80; Jouyban-Acree model; Micellar effect; Cosolvency;
Keywords: لاموتریژین; AE; absence epilepsy; CSD; current source density; CZ; clonazepam; IGE; idiopathic generalized epilepsy; JME; juvenile myoclonic epilepsy; LEV; levetiracetam; LORETA; low resolution electromagnetic tomography; LTG; lamotrigine; VPA; valproate; Absence epi
Keywords: لاموتریژین; Epilepsy; Kindling; Lamotrigine; Pharmacoresistant; Supplementation; Taurine;
Keywords: لاموتریژین; Comparative fit index; CFI; Lamotrigine; LTG; People with epilepsy; PWE; Root mean square of error approximation; RMSEA; Sexual Attitudes and Beliefs Survey; SABS; Structural equation modeling; SEM; Standardized root mean square residual; SRMR; Tucker-L
Keywords: لاموتریژین; Sodium valproate; Lamotrigine; Body mass index; Insulin resistance; Adiponectin;
Keywords: لاموتریژین; ADD; attention deficit disorder; ADHD; Attention deficit hyperactivity syndrome; AEDs; antiepileptic drugs; b/p; blood-to-plasma ratio; CBZ; carbamazepine; CI; confidence interval; DBS; dried blood spots; EMA; European Medicines Agency; HCT; hematocrit; L
Keywords: لاموتریژین; Valproic acid; Lamotrigine; Generalized epilepsies; Monotherapy; Meta-analysis;
Keywords: لاموتریژین; BCH; 2-Amino-2-norbornanecarboxylic acid; CBZ; carbamazepine; CLB; clobazam; CZP; clonazepam; GBP; gabapentin; LAT; l-type amino acid transporter; LC/MS/MS; liquid chromatography/tandem mass spectrometry; LEV; levetiracetam; LTG; lamotrigine; NZP; nitraze
Keywords: لاموتریژین; HBO2; hyperbaric oxygen; ATA; atmospheres absolute; AED; antiepileptic drug; CBZ; carbamazepine; GBP; gabapentin; LTG; lamotrigine; OXC; oxcarbazepine; PRM; primidone; TGB; tiagabine; VGB; vigabatrin; VPA; valproic acid; ZNS; zonisamide; Antiepileptic dru
Keywords: لاموتریژین; Refractory epilepsy; Dose-response; Lamotrigine; Valproate; Pharmacodynamic synergy;
Keywords: لاموتریژین; Lamotrigine; Brugada syndrome; Ventricular arrhythmias; Ajmaline; Sodium channel blockade;
Keywords: لاموتریژین; B-DMIHM; boron-embedded duplex molecularly imprinted hybrid membrane; GR; graphene; SWV; square wave voltammetry; DPV; different pulse voltammetry; Lamotrigine; Computational design; Duplex molecularly imprinted hybrid membrane; Electrochemical sensor;
Keywords: لاموتریژین; Lamotrigine (PubChem CID: 3878); 4,4â²-Bipyridine (PubChem CID: 11107); 2,2â²-Bipyridine (PubChem CID: 1474); Lamotrigine; Cocrystal screening; Isomeric bipyridines; Cocrystallization process; Dissolution;
A new “turn-on” fluorescent sensor based on gold quantum dots and silver nanoparticles for lamotrigine detection in plasma
Keywords: لاموتریژین; Lamotrigine; 4-Aminothiophenol-stabilized gold quantum dots; Amidosulfonic acid-capped silver nanoparticles; Fluorescence resonance energy transfer;
Keywords: لاموتریژین; Oral disintegrating films; Quality by design; Process variables; Formulation; Film former; Lamotrigine; Critical quality attributes;
Keywords: لاموتریژین; AED; antiepileptic drug; VPA; valproic acid; CBZ; carbamazepine; OXC; oxcarbazepine; LEV; levetiracetam; LTG; lamotrigine; TPM; topiramate; VIQ; verbal intelligence quotient; PIQ; performance intelligence quotient; HINE; Hammersmith Infant Neurological Ex
Keywords: لاموتریژین; Bipolar disorder; Lithium; Lamotrigine; Quetiapine; Mood stabilizers; Antidepressants;
Keywords: لاموتریژین; Lamotrigine; Bioanalytical method validation; High-performance liquid chromatography; Microextraction by packed sorbent; Rat plasma and brain;
Keywords: لاموتریژین; Valproate; Lamotrigine; Carbamazepine; Antiepileptic; Pregnancy; Behavior
Keywords: لاموتریژین; Epilepsy; Comedication; Korean; Lamotrigine; Pharmacokinetics; Clearance;
Keywords: لاموتریژین; AED; anti-epileptic drug; BMI; body mass index; CBZ; carbamazepine; CLB; clobazam; CLZ; clonazepam; CWO; control children; CWE; children of women with epilepsy; DDD; daily defined dose; FSIQ; Full Scale IQ; KREP; Kerala Registry of Epilepsy and Pregnancy;
Keywords: لاموتریژین; Alcohol; Beta-endorphin; Free-choice procedure; Lamotrigine; Warsaw high-preferring rats; WHP;
Keywords: لاموتریژین; Antiepileptic drugs; Lamotrigine; Stevens–Johnson syndrome; Toxic epidermal necrolysis
Keywords: لاموتریژین; Lamotrigine; Children; Drug interaction; Therapeutic drug monitoring; Pharmacokinetics
Keywords: لاموتریژین; CAE; childhood absence epilepsy; TAS; typical absence seizures; IGE; idiopathic generalized epilepsies; AEDs; anti-epileptic drugs; IQ; intelligence quotient; WISC; Wechsler Intelligence Scale for Children; NIH; National Institutes of Health; NINDS; Natio
Keywords: لاموتریژین; Lamotrigine; Intranasal administration; Pharmacokinetics; Nose-to-brain drug delivery; Brain biodistribution; Mice
Keywords: لاموتریژین; Column selection system; RP-LC analysis; Partial Least Squares; Alfuzosin hydrochloride; Lamotrigine; Impurities;
Keywords: لاموتریژین; Lamotrigine; Rash; Incidence; Prospective study; Meta-analysis
Keywords: لاموتریژین; Antiepileptic drugs; Ketogenic diet; Lamotrigine; Children; Epilepsy; Efficacy;
Keywords: لاموتریژین; AAN; American Academy of Neurology; AED; antiepileptic drug; AES; American Epilepsy Society; CA; California; CBZ; carbamazepine; CVD; cerebrovascular disease; FDA; Federal Drug Administration (Food and Drug Administration in the Introduction); FY; fiscal
Keywords: لاموتریژین; lamotrigine; bipolar I disorder; pediatric; adolescent; adjunctive therapy;
Keywords: لاموتریژین; Lamotrigine; Lithium; Valproate; Quetiapine; Aripiprazole; Olanzapine;
Keywords: لاموتریژین; Antiepileptic drugs; Lamotrigine; Topiramate; Bone mineral density; Bone markers;
Keywords: لاموتریژین; Pregnancy; Epilepsy; Lamotrigine; Anti-epileptic drugs; Monitoring;
Keywords: لاموتریژین; Epilepsy; Lamotrigine; Treatment outcome; Prognosis; Effect modifiers;
Keywords: لاموتریژین; Antidepressants; Antipsychotics; Olanzapine plus fluoxetine; Quetiapine; Lurasidone; Lamotrigine; Antidepressants; Armodafinil; Bipolar depression; Bipolar disorder; Mood stabilizers; Number needed to harm; Number needed to treat